A single day rise of 62,224 new coronavirus infections were reported taking India’s total tally of COVID-19 cases to 2,96,33,105, while the active cases were recorded below nine lakh after 70 days. The COVID-19 death toll climbed to 3,79,573 with 2,542 fresh fatalities, according to the Health Ministry on Wednesday.
A net decline of 47,946 cases has been recorded in the COVID-19 caseload in a span of 24 hours.
The decision regarding enhancing interval between two doses of Covishield was based on scientific evidence and taken in a transparent manner, NTAGI Chair N K Arora said on Tuesday.
There was no dissenting voice among the members of the National Technical Advisory Group on Immunization (NTAGI ), he said, according to a tweet by the Union Health Ministry.
The government had on May 13 said it has accepted the COVID-19 Working Group’s recommendation and extended the gap between the two doses of the Covishield vaccine from 6-8 weeks to 12-16 weeks.
“Based on the available real-life evidence, particularly from the UK, the COVID-19 Working Group agreed for increasing the dosing interval to 12-16 weeks between two doses of Covishield vaccine. No change in the interval of Covaxin vaccine doses was recommended,” the ministry had said in a statement.
“The recommendation of the COVID-19 Working Group was accepted by the National Expert Group on Vaccine Administration for COVID-19 (NEGVAC), headed by Dr V K Paul, Member (Health), Niti Aayog, in its meeting on May 12, 2021,” the ministry said.
It has accepted this recommendation of the COVID-19 Working Group of extension of the gap between the first and second doses of Covishield to 12-16 weeks, the health ministry added.